1

================================================================================

                     U.S. SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                 AMENDMENT NO. 1
                                       TO
                                    FORM 10-Q

                QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
                     OF THE SECURITIES EXCHANGE ACT OF 1934

                  FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2001


                         Commission file number 0-28288

                              --------------------

                            CARDIOGENESIS CORPORATION
             (Exact name of Registrant as specified in its charter)

                             ----------------------

             CALIFORNIA                          77-0223740
      ------------------------             ----------------------
      (State of incorporation)                (I.R.S. Employer
                                           Identification Number)

                       26632 TOWNE CENTRE DRIVE, SUITE 320
                            FOOTHILL RANCH, CA 92610
                    (Address of principal executive offices)

                                 (714) 649-5000
              (Registrant's telephone number, including area code)

                       ECLIPSE SURGICAL TECHNOLOGIES, INC.
                      1049 KIEL COURT, SUNNYVALE, CA 94089
                  (Registrant's Former Name and Former Address)


     Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.
                                 Yes [X] No [ ]

     Indicate the number of shares outstanding of each of the issuer's classes
of common stock outstanding as of the latest practicable date.

                 34,209,065 shares of Common Stock, no par value
                               As of July 31, 2001

================================================================================

   2

                                EXPLANATORY NOTE

     This Amendment No. 1 on Form 10-Q/A amends and restates Part II, Item 6 of
CardioGenesis Corporation's Quarterly Report on Form 10-Q for its fiscal quarter
ended June 30, 2001 filed with the Securities and Exchange Commission on August
14, 2001. This Amendment is necessary in order to add as Exhibit 10.1
CardioGenesis' Property Lease for its Foothill Ranch facility entered into May
7, 2001 between CardioGenesis Corporation and Foothill Operon I, LLC.

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

     a)   Exhibits required to be filed by Item 601 of Regulation S-K:

   EXHIBIT
   NUMBER      DESCRIPTION
   ------      -----------

     3.1       Amended and Restated Bylaws of CardioGenesis Corporation adopted
               as of April 11, 2001 herein incorporated by reference from
               CardioGenesis' Form 8-K filed on April 23, 2001.

     3.2       Certificate of Amendment to Articles of Incorporation of
               CardioGenesis Corporation filed with the Secretary of State of
               California on June 18, 2001.

     10.1      Property Lease for Foothill Ranch facility entered into May 7,
               2001 between CardioGenesis Corporation (formerly known as Eclipse
               Surgical Technologies, Inc.) and Foothill Operon I, LLC.

     b)   Reports on Form 8-K

          (i) A report on Form 8-K was filed on April 23, 2001, to report under
     Item 5, Other Events, CardioGenesis' sale of common stock to the State of
     Wisconsin Investment Board and amendment to CardioGenesis' Bylaws.

          (ii) A report on Form 8-K was filed on June 20, 2001, to report under
     Item 5, Other Events, the change of CardioGenesis' name from its former
     name of Eclipse Surgical Technologies, Inc. (Nasdaq: ESTI) to CardioGenesis
     Corporation (Nasdaq: CGCP).


                                       2

   3

                            CARDIOGENESIS CORPORATION

                                   SIGNATURES


     Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.


                                                       CARDIOGENESIS CORPORATION
                                                       Registrant


Date: August 16, 2001                                  /s/ Michael J. Quinn
                                                       -------------------------
                                                           Michael J. Quinn
                                                           Chief Executive
                                                           Officer, President
                                                           and Chairman of the
                                                           Board (Principal
                                                           Executive Officer)



Date: August 16, 2001                                  /s/ J. Stephen Wilkins
                                                       -------------------------
                                                           J. Stephen Wilkins
                                                           Vice President and
                                                           Chief Financial
                                                           Officer (Principal
                                                           Accounting and
                                                           Financial Officer)


                                       3
   4

                                 EXHIBIT INDEX


   EXHIBIT
   NUMBER      DESCRIPTION
   ------      -----------

     3.1       Amended and Restated Bylaws of CardioGenesis Corporation adopted
               as of April 11, 2001 herein incorporated by reference from
               CardioGenesis' Form 8-K filed on April 23, 2001.

     3.2       Certificate of Amendment to Articles of Incorporation of
               CardioGenesis Corporation filed with the Secretary of State of
               California on June 18, 2001.

     10.1      Property Lease for Foothill Ranch facility entered into May 7,
               2001 between CardioGenesis Corporation (formerly known as Eclipse
               Surgical Technologies, Inc.) and Foothill Operon I, LLC.